Target intelligence / Profile preview

Enterovirus A71 capsid protein VP3 (BC loop and knob region) (EV-A71 VP3)

Target
EV-A71 VP3
Molecular classification
Viral structural protein, Viral capsid protein
01

Overview

Enterovirus A71 (EV-A71) capsid protein VP3 is a major structural component of the viral icosahedral shell, essential for maintaining particle integrity and facilitating host cell entry (Plevka et al., 2012, Nature Structural & Molecular Biology). The BC loop and the knob region of VP3 are prominent surface-exposed loops that contribute to the structural landscape of the viral capsid and serve as critical neutralizing epitopes (Plevka et al., 2012). While the primary receptor SCARB2 interacts with multiple capsid proteins, the VP3 regions are essential for the overall stability and the conformational changes required for genome release (Zhou et al., 2019, Nature Communications). Monoclonal antibodies such as D5 and 1H2 specifically target the VP3 knob region, effectively neutralizing the virus by preventing attachment or inhibiting the uncoating process (Wang et al., 2012, Nature Structural & Molecular Biology). In clinical contexts, EV-A71 is the primary causative agent of Hand, Foot, and Mouth Disease (HFMD), which can progress to severe neurological complications such as encephalitis and acute flaccid paralysis (Solomon et al., 2010, Lancet Infectious Diseases). Because the VP3 BC loop and knob are highly conserved among various EV-A71 genotypes, they are prime targets for the development of broad-spectrum vaccines and therapeutic antibodies. However, the potential for antigenic drift and the theoretical risk of antibody-dependent enhancement (ADE) remain significant challenges in targeting these viral surfaces (Zhang et al., 2014, Journal of Virology).

Other names
EV71 VP3Enterovirus 71 capsid protein 3VP3 BC loopVP3 knob region
02

Mechanism of action

Neutralization of viral infectivity by blocking receptor binding or preventing viral uncoating.

03

Biological functions

Viral attachmentViral entryCapsid assemblyReceptor binding
04

Disease associations

Hand, foot, and mouth diseaseEncephalitisAseptic meningitisAcute flaccid paralysis
05

Safety considerations

Viral escape mutationsPotential for antibody-dependent enhancement (ADE)Cross-reactivity with other enteroviruses
06

Interacting drugs

D5 monoclonal antibody

2 more in the full profile.

07

Biomarkers

VP3-specific neutralizing antibody titersEV-A71 viral RNA levels

Beyond the preview

Go deeper on Enterovirus A71 capsid protein VP3 (BC loop and knob region) (EV-A71 VP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterovirus A71 capsid protein VP3 (BC loop and knob region) (EV-A71 VP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call